<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Vexas on Rheumatology Digest</title><link>https://rheumatologydigest.org/tags/vexas/</link><description>Recent content in Vexas on Rheumatology Digest</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Sat, 15 Aug 2026 05:00:00 +0530</lastBuildDate><atom:link href="https://rheumatologydigest.org/tags/vexas/index.xml" rel="self" type="application/rss+xml"/><item><title>Relapsing Polychondritis: Clusters and VEXAS</title><link>https://rheumatologydigest.org/posts/relapsing-polychondritis-clusters-vexas/</link><pubDate>Sat, 15 Aug 2026 05:00:00 +0530</pubDate><guid>https://rheumatologydigest.org/posts/relapsing-polychondritis-clusters-vexas/</guid><description>A tenth of &amp;#39;RP&amp;#39; is VEXAS, and mortality across the three clusters spans 4% to 58% — the label alone now carries almost no prognostic information.</description></item></channel></rss>